Gait disturbance: FDA reporting patterns
189,394 FDA FAERS reports mention Gait disturbance. 122,003 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 10,899 reports
- Dalfampridine: 9,613 reports
- Etanercept: 9,525 reports
- Natalizumab: 8,951 reports
- Interferon Beta-1a: 7,025 reports
- Methotrexate: 5,484 reports
- Pregabalin: 5,172 reports
- Dimethyl Fumarate: 4,051 reports
- Tofacitinib: 4,035 reports
- Fingolimod: 3,656 reports
- Rituximab: 3,524 reports
- Secukinumab: 3,435 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.